500
0
0
Skip to Content
Lung Cancer Europe | Advocacy and Access for Lung Cancer in Europe
🔍
Overview
Our Board
Brand hub
Contact
Annual Reports
English
Lung Cancer Europe | Advocacy and Access for Lung Cancer in Europe
🔍
Overview
Our Board
Brand hub
Contact
Annual Reports
English
🔍
Folder: Who We Are
Back
Overview
Our Board
Brand hub
Contact
Annual Reports
English
Back
No results found
Lung cancer screening in Europe: how do we make access fair?
Screening, Advocacy, News Web Team 25/08/2026 Screening, Advocacy, News Web Team 25/08/2026

Lung cancer screening in Europe: how do we make access fair?

Read More
What do jellyfish and fireflies have to do with lung cancer research?
Research, News Web Team 24/08/2026 Research, News Web Team 24/08/2026

What do jellyfish and fireflies have to do with lung cancer research?

Read More
PhD research uncovers new cell population that may help lung cancer suppress the immune system
Research, News Web Team 23/08/2026 Research, News Web Team 23/08/2026

PhD research uncovers new cell population that may help lung cancer suppress the immune system

Read More
Younger people with lung cancer may be more likely to have targetable genetic changes
News, Research, Advocacy, Treatment Web Team 22/08/2026 News, Research, Advocacy, Treatment Web Team 22/08/2026

Younger people with lung cancer may be more likely to have targetable genetic changes

Read More
Personalised cancer vaccine succeeds in Phase 3: what could it mean for lung cancer?
News, Research, Advocacy Web Team 20/08/2026 News, Research, Advocacy Web Team 20/08/2026

Personalised cancer vaccine succeeds in Phase 3: what could it mean for lung cancer?

Read More
Hotter Summers, Dirtier Air: Heatwaves and Lung Cancer in Europe
Prevention & risk, Advocacy, News Web Team 16/08/2026 Prevention & risk, Advocacy, News Web Team 16/08/2026

Hotter Summers, Dirtier Air: Heatwaves and Lung Cancer in Europe

Read More
Who counts as a lung cancer expert?
Advocacy, News, Policy Web Team 12/08/2026 Advocacy, News, Policy Web Team 12/08/2026

Who counts as a lung cancer expert?

Read More
Lung cancer staging: is TNM still enough?
News, Research, Diagnosis Web Team 07/08/2026 News, Research, Diagnosis Web Team 07/08/2026

Lung cancer staging: is TNM still enough?

Read More
Small cell lung cancer webinar: help us spread the word
News, Advocacy, Treatment Web Team 06/08/2026 News, Advocacy, Treatment Web Team 06/08/2026

Small cell lung cancer webinar: help us spread the word

Read More
Biomarker testing is moving faster than ever. Is Europe keeping up?
Research, Treatment, Advocacy, News Web Team 05/08/2026 Research, Treatment, Advocacy, News Web Team 05/08/2026

Biomarker testing is moving faster than ever. Is Europe keeping up?

Read More
Backing the call for a European Lung Health Plan
News, Advocacy Web Team 02/08/2026 News, Advocacy Web Team 02/08/2026

Backing the call for a European Lung Health Plan

Read More
World Lung Cancer Day: The Years We Don’t Count
Advocacy, News Web Team 01/08/2026 Advocacy, News Web Team 01/08/2026

World Lung Cancer Day: The Years We Don’t Count

Read More
Get Checked 2026
Advocacy, Diagnosis, News Web Team 01/08/2026 Advocacy, Diagnosis, News Web Team 01/08/2026

Get Checked 2026

Read More
Wildfire smoke and lung cancer: what does the evidence show?
News, Prevention & risk, Advocacy, Research Web Team 28/07/2026 News, Prevention & risk, Advocacy, Research Web Team 28/07/2026

Wildfire smoke and lung cancer: what does the evidence show?

Read More
A new ROS1 lung cancer drug has reached patients in the US. What happens next in Europe?
Treatment, Access, News Web Team 25/07/2026 Treatment, Access, News Web Team 25/07/2026

A new ROS1 lung cancer drug has reached patients in the US. What happens next in Europe?

Read More
Lung Cancer Europe’s position on artificial intelligence in lung cancer care
News, Treatment, Advocacy, Research Web Team 25/07/2026 News, Treatment, Advocacy, Research Web Team 25/07/2026

Lung Cancer Europe’s position on artificial intelligence in lung cancer care

Read More
Why People with Lung Cancer Face a Higher Risk of Hospital Infections
Prevention & risk, Policy, Treatment, Advocacy, LuCE News, News Web Team 24/07/2026 Prevention & risk, Policy, Treatment, Advocacy, LuCE News, News Web Team 24/07/2026

Why People with Lung Cancer Face a Higher Risk of Hospital Infections

Read More
Europe's next long term budget: new briefing highlights key issues for lung cancer
Policy, News, Advocacy Web Team 20/07/2026 Policy, News, Advocacy Web Team 20/07/2026

Europe's next long term budget: new briefing highlights key issues for lung cancer

Read More
BMI, the Gut Microbiome and Immunotherapy: New Nature Study Explores the Obesity Paradox
News, Treatment, Research Web Team 19/07/2026 News, Treatment, Research Web Team 19/07/2026

BMI, the Gut Microbiome and Immunotherapy: New Nature Study Explores the Obesity Paradox

Read More
TROP2 and lung cancer: what we know so far
News, Treatment, Research Web Team 17/07/2026 News, Treatment, Research Web Team 17/07/2026

TROP2 and lung cancer: what we know so far

Read More
Older Posts

With Thanks to Our Supporters

Lung Cancer Europe is grateful to the partners who share our commitment to people affected by lung cancer. Their support helps us turn our mission into action across research, education and advocacy.

Accord Healthcare Amgen Bayer AstraZeneca BeOne Medicines BioNTech Blueprint Medicines Bristol Myers Squibb Boehringer Ingelheim Daiichi Sankyo Genmab Gilead Johnson & Johnson Lilly Merck Group MSD Novartis Novocure Pfizer PharmaCosmos PharmaMar Pierre Fabre Regeneron Roche Takeda Thermo Fisher

Connect with us on LinkedIn

Stay in the loop

You can subscribe to updates from Lung Cancer Europe by signing up to our monthly newsletter below. Our newsletter goes out on 1st of every month and we also send out news bulletins and updates.

By signing up, you agree to receive emails from Lung Cancer Europe. You can unsubscribe at any time. Read our Privacy Policy to learn how we handle your data.

PRIVACY POLICY

© Lung Cancer Europe 2026 | Designed by Laura Jones